Yunnan Botanee Biotechnology Group Co.
A Kunming-based skin-health and beauty group that develops, manufactures, markets, and serves skincare and related offerings, with Winona as its leading brand.
Last updated October 12, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Yunnan Botanee Biotechnology Group Co. (Botanee; 云南贝泰妮生物科技集团股份有限公司) is a Chinese skin-health and beauty group founded in 2010. The company describes itself as an internet-plus health-industry group focused on skin health, integrating research and development, production, marketing, and services. Its stated ambition is to build a Chinese skin-health ecosystem and contribute to the development of China's broader skin-health sector. The company is based in Kunming, Yunnan, and has been listed on the Shenzhen Stock Exchange ChiNext since March 25, 2021, under stock code 300957. Research and product development are central to Botanee's stated approach. The company says it combines industry, academia, research, and medical expertise, drawing on fields including botany, biology, and dermatology, and investigates active ingredients in distinctive Yunnan plants. Its corporate website presents scientific research, skin-health expertise, and product safety and efficacy as foundations of its offering. The group also describes a channel strategy combining offline pharmaceutical channels with broad online coverage, alongside an online-to-offline, or OMO, retail system that uses internet and artificial-intelligence technologies. Botanee's portfolio is organized around multiple brands. Winona (薇诺娜), its leading brand, specializes in sensitive skin and positions itself as a dermatology-oriented, efficacy-skincare brand. The group's other brands and offerings described on its website include AOXMED (瑷科缦), focused on professional beauty and skin-ageing care; Beautini (贝芙汀), which offers an integrated acne-care approach; Winona Baby (薇诺娜宝贝), focused on infant and child skincare, particularly eczema; and Tripollar (初普), a home-use beauty-device brand. These descriptions represent the group’s stated brand propositions and do not imply that every offering is available in every market. The group reports milestones in its research, manufacturing, and commercial development, including establishing a group research center in 2013, receiving investment from Sequoia Capital in 2014, beginning construction of a central-factory project in 2020, listing in 2021, and bringing its central factory into operation in 2023. Its current public-facing identity emphasizes scientific innovation, the use of Yunnan botanical resources, skin-health services, and sustainability. Botanee states that it is incorporating ESG principles into its long-term development and supports initiatives related to biodiversity, access to health, and education.
History
Yunnan Botanee Biotechnology Group Co. was established in 2010 as the predecessor company Kunming Botanee Biotechnology Co., according to the company's account of its development. Its origins and subsequent development are tied to the company's stated focus on skin health, research, and the development of efficacy skincare. The corporate website describes a business combining research and development, production, marketing, and services, and says its work draws on the intersection of industry, academia, research, and medicine. The company records a series of research and institutional developments in its timeline. In 2012 it became a participating organization in a Yunnan higher-education collaborative innovation center project. In 2013 it established a group research center and set up its subsidiary Shanghai Botanee Biotechnology Co. In 2014 it received investment from Sequoia Capital. The company says it was recognized as a national high-tech enterprise in 2015, the same year Winona appeared at the World Congress of Dermatology. In 2016 the Qiumei app launched, and in 2017 Botanee was selected as a member organization of an innovation-team collaboration associated with China's Ministry of Education. The company reports that its quality-management system received GMPC and ISO 22716:2007 (E) certification in 2018. In 2019 it was awarded a Yunnan provincial postdoctoral research workstation and reported that Winona ranked among the top nine in Tmall's Double 11 beauty and skincare category. In 2020 construction began on the Botanee central-factory project in Majinpu, Kunming. Botanee says it officially listed on the Shenzhen Stock Exchange ChiNext on March 25, 2021, with stock code 300957. In 2022 it led the construction of a Yunnan characteristic-plant extraction laboratory, and in 2023 its central factory formally began production. The group's more recent public account continues to emphasize scientific research, botanical resources, and a portfolio of specialist brands. Winona is identified as the group's leading brand and focuses on sensitive skin. The official site also presents AOXMED, Beautini, Winona Baby, and Tripollar, each with a distinct stated focus ranging from professional skin-ageing care to acne care, infant skincare, and home-use beauty devices. The company describes a retail approach combining offline pharmaceutical channels with broad online coverage and an OMO system supported by internet and artificial-intelligence technologies. Botanee's corporate communications also frame sustainability as part of its long-term development. The company says it is incorporating ESG principles and undertaking initiatives related to biodiversity conservation, access to health, and education under a 2030 sustainability strategy. These are the company's stated commitments; the supplied material does not establish further outcome measures.
- 2025
Winona Double 11 Top 10 streak continued
- 2024
Winona Double 11 Top 10 streak
- 2023
Central factory began operations
- 2022
Yunnan characteristic-plant extraction laboratory
- 2021
Listed on the Shenzhen Stock Exchange ChiNext
- 2020
Central-factory project construction began
- 2019
Postdoctoral research workstation and Tmall ranking
- 2018
Quality-management certifications
- 2017
Selected for an innovation-team collaboration
- 2016
Qiumei app launched
Products and positioning
A science- and dermatology-oriented Chinese skin-health group with a multi-brand portfolio, use of Yunnan botanical resources, and integrated online and offline channels.
Winona (薇诺娜)
The group's leading dermatology-oriented skincare brand, specializing in sensitive skin and efficacy skincare.
AOXMED (瑷科缦)
A professional-beauty and skin-ageing-care brand offering clinic and home skincare solutions, as described by the company.
Beautini (贝芙汀)
A brand offering an integrated, personalized acne-care approach described as combining food, medicine, and skincare.
Winona Baby (薇诺娜宝贝)
An infant and child skincare brand focused particularly on infant and child eczema care.
Tripollar (初普)
A home-use beauty-device brand described as adapting professional salon technologies for home use.
Controversies
Brand decisions
- Adopted a multi-brand strategy centered on WinonaOther
- Combined offline pharmaceutical channels with online coverageOther
- Integrated ESG into long-term developmentOther
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/yunnan-botanee-biotechnology-group-co · Editorial policy · How profiles are compiled